The ERBB3 receptor in cancer and cancer gene therapy
Open Access
- 11 April 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 15 (7), 413-448
- https://doi.org/10.1038/cgt.2008.15
Abstract
No abstract availableKeywords
This publication has 196 references indexed in Scilit:
- The HER family and cancer: emerging molecular mechanisms and therapeutic targetsTrends in Molecular Medicine, 2007
- Systematic search for the best gene expression markers for melanoma micrometastasis detectionThe Journal of Pathology, 2007
- The ErbB4 receptor in fetal rat lung fibroblasts and epithelial type II cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Downregulation of erbB3 abrogates erbB2‐mediated tamoxifen resistance in breast cancer cellsInternational Journal of Cancer, 2007
- Constitutive Activation of Neuregulin/ERBB3 Signaling Pathway in Clear Cell Sarcoma of Soft TissueNeoplasia, 2006
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006
- Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancersInternational Journal of Cancer, 2006
- Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol‐3 kinase pathways in non‐small cell lung cancer cellsInternational Journal of Cancer, 2005
- Expression of the HER1–4 family of receptor tyrosine kinases in breast cancerThe Journal of Pathology, 2003